These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 24281100)

  • 1. Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studies.
    Le Page C; Huntsman DG; Provencher DM; Mes-Masson AM
    Cancers (Basel); 2010 May; 2(2):913-54. PubMed ID: 24281100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the management of epithelial ovarian cancer.
    Berkenblit A; Cannistra SA
    J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas.
    Le Page C; Chung J; Rahimi K; Köbel M; Provencher D; Mes-Masson AM
    Curr Drug Targets; 2020; 21(10):974-995. PubMed ID: 31622218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic and prognostic value of tumor markers, scores (clinical and biological) algorithms, in front of an ovarian mass suspected of an epithelial ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Bendifallah S; Body G; Daraï E; Ouldamer L
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):134-154. PubMed ID: 30733191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gynecological malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers.
    Le Page C; Rahimi K; Köbel M; Tonin PN; Meunier L; Portelance L; Bernard M; Nelson BH; Bernardini MQ; Bartlett JMS; Bachvarov D; Gotlieb WH; Gilks B; McAlpine JN; Nachtigal MW; Piché A; Watson PH; Vanderhyden B; Huntsman DG; Provencher DM; Mes-Masson AM
    BMC Cancer; 2018 Mar; 18(1):347. PubMed ID: 29587661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic biomarkers in epithelial ovarian cancer.
    Gloss BS; Samimi G
    Cancer Lett; 2014 Jan; 342(2):257-63. PubMed ID: 22245949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The molecular biology of epithelial ovarian cancer].
    Leary A; Pautier P; Tazi Y; Morice P; Duvillard P; Gouy S; Uzan C; Gauthier H; Balleyguier C; Lhommé C
    Bull Cancer; 2012 Dec; 99(12):1161-73. PubMed ID: 23238064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
    Petrillo M; Marchetti C; De Leo R; Musella A; Capoluongo E; Paris I; Benedetti Panici P; Scambia G; Fagotti A
    Am J Obstet Gynecol; 2017 Sep; 217(3):334.e1-334.e9. PubMed ID: 28549976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer.
    Lukanović D; Herzog M; Kobal B; Černe K
    Biomed Pharmacother; 2020 Sep; 129():110401. PubMed ID: 32570116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.
    Pereira E; Camacho-Vanegas O; Anand S; Sebra R; Catalina Camacho S; Garnar-Wortzel L; Nair N; Moshier E; Wooten M; Uzilov A; Chen R; Prasad-Hayes M; Zakashansky K; Beddoe AM; Schadt E; Dottino P; Martignetti JA
    PLoS One; 2015; 10(12):e0145754. PubMed ID: 26717006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery.
    Muraji M; Sudo T; Iwasaki S; Ueno S; Wakahashi S; Yamaguchi S; Fujiwara K; Nishimura R
    Gynecol Oncol; 2013 Dec; 131(3):531-4. PubMed ID: 24096109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of immunohistochemistry in prognostic assessment of epithelial ovarian carcinoma --review of the literature I.
    Tomsová M; Melichar B
    Acta Medica (Hradec Kralove); 2006; 49(3):161-5. PubMed ID: 17117604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer.
    Gadducci A; Cosio S; Tana R; Genazzani AR
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):12-27. PubMed ID: 18595727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer.
    Krzystyniak J; Ceppi L; Dizon DS; Birrer MJ
    Ann Oncol; 2016 Apr; 27 Suppl 1(Suppl 1):i4-i10. PubMed ID: 27141069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer.
    Cáceres-Gorriti KY; Carmona E; Barrès V; Rahimi K; Létourneau IJ; Tonin PN; Provencher D; Mes-Masson AM
    PLoS One; 2014; 9(3):e91000. PubMed ID: 24625450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer.
    Gunn S; Reveles X; Weldon K; Barrera A; Ishaque M; Taylor D; McCaskill C; Kim J; Shah R; Mohammed M; Barry T; Kaiser B; Patnaik A; Tolcher A
    J Ovarian Res; 2013 Jan; 6(1):2. PubMed ID: 23289505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.